Which Screenings and Tests Should Women Have?

Nov 18, 2026 | Wellcare Laboratories
Which Screenings and Tests Should Women Have?

Which Screenings and Tests Should Women Have?

Regular health checks can help detect some diseases before symptoms appear. However, not every woman needs the same blood tests every year. Age, family history, pregnancies, medications, symptoms and individual risks affect which tests are needed and when. The information below is a general guide for people at average risk; national screening programmes and doctors' recommendations may vary.

 

Checks to consider at any age

  1. Blood pressure: Measurement is recommended during regular health checks. If blood pressure is normal, an annual check may be appropriate; higher readings require more frequent monitoring.
  2. Lipid profile: Includes total cholesterol, LDL, HDL and triglycerides. The American Heart Association recommends testing from age 20 in adults at average risk, generally with follow-up every 4–6 years; the interval may be shorter if there is a family history of premature cardiovascular disease or other risks.
  3. Lp(a): Not included in a standard cholesterol test. The American Heart Association recommends that every adult have it measured at least once in their lifetime. It may be particularly relevant if there is a family history of heart attack or stroke at an early age, elevated Lp(a) or familial hypercholesterolaemia. It generally does not need to be repeated every year.
  4. HIV, hepatitis B and hepatitis C screening: The CDC recommends screening for these infections at least once in adulthood; repeat testing may be needed if there is ongoing risk. These recommendations may differ from local screening programmes.

 

Key screenings by age

Age groupKey screenings
18–20 yearsBlood pressure and general health assessment. Annual screening for chlamydia and gonorrhoea in sexually active women (CDC: under 25). HIV testing at least once if not previously performed; hepatitis B and C screening may also be considered at least once in adulthood.
21–24 yearsScreenings from the previous age group continue. Cervical cancer screening may begin at these ages, depending on the programme used; one US recommendation includes a Pap smear every 3 years for ages 21–29.
25–29 yearsChlamydia and gonorrhoea screening is performed if there is a risk; for example, a new partner or multiple partners, a partner with an STI or a previous history of STIs. Cervical screening continues according to the local programme.
30–34 yearsChlamydia and gonorrhoea screening if there is a risk. Depending on the programme, cervical screening may involve HPV testing, combined HPV testing and a Pap smear, or a Pap smear alone.
35–39 yearsDiabetes screening with HbA1c, fasting glucose or OGTT may be considered. The ADA recommends starting general adult screening at age 35 and repeating it at least every 3 years if the result is normal; earlier or more frequent assessment may be needed if there are risk factors.
40–44 yearsFor women at average risk of breast cancer, mammography may be performed every 2 years from age 40, according to the USPSTF recommendation. Cholesterol and blood glucose monitoring are considered alongside individual risk.
45–49 yearsColorectal cancer screening may begin at age 45. Options include an annual FIT test or colonoscopy every 10 years. Mammography and diabetes/cholesterol monitoring continue.
50–64 yearsBreast, cervical and colorectal cancer screening continues at the recommended intervals.
65 years and overOsteoporosis screening is considered using bone density measurement, particularly in women aged 65 and over. Cervical screening may be discontinued in people with adequate previous negative results who are not at high risk.

The CDC recommends annual chlamydia and gonorrhoea screening for sexually active women under 25, and screening for those aged 25 and over if they are at risk. During pregnancy, HIV, syphilis, hepatitis B and hepatitis C screening is performed at the first prenatal visit; chlamydia and gonorrhoea screening is recommended for those under 25 or for older individuals if they are at risk. Repeat testing later in pregnancy may be needed if the risk continues.

HIV testing is considered at least once between ages 13–64 if not previously performed, and hepatitis B and C testing at least once in adulthood. Repeat testing may be planned if there is an ongoing risk of exposure. Routine herpes blood testing or a broad panel covering every STI in people without symptoms is not part of the CDC's general screening recommendations.

 

Cervical cancer: HPV testing and Pap smears

HPV testing and Pap smears help detect precancerous changes in the cervix. An annual Pap smear is not necessary for everyone. For example, the 2025 US WPSI recommendations specify a Pap smear every 3 years between ages 21–29, and high-risk HPV testing every 5 years as the preferred option between ages 30–65. If HPV testing is unavailable, a Pap smear every 3 years is also an option. As the starting age and method may vary by country, the local programme and your doctor's recommendations should be followed.

Having received the HPV vaccine does not eliminate the need for screening. Follow-up is planned separately for people who have had a hysterectomy or have previously been treated for a high-grade cervical lesion.

 

Breast cancer: mammography

For women at average risk, the US USPSTF guideline recommends mammography every two years between the ages of 40–74. If there is a family history of breast or ovarian cancer, a known hereditary risk, or a history of a previous biopsy, screening may start earlier or additional examinations may be included. National programmes may specify different ages and intervals. If there is a new breast lump, skin dimpling or bloody nipple discharge, a doctor should be consulted without waiting until screening age.

 

Colorectal cancer: stool testing or colonoscopy

US USPSTF recommendations include starting colorectal cancer screening at age 45 for people at average risk. Options include an annual faecal occult blood/FIT test or a colonoscopy every 10 years. An abnormal stool test result should be evaluated with a colonoscopy. If there is a family history of bowel cancer at an early age, polyps, inflammatory bowel disease or a hereditary cancer risk, screening may be scheduled earlier and more frequently.

 

HbA1c and blood glucose

HbA1c, fasting glucose or an oral glucose tolerance test can be used to screen for diabetes. The American Diabetes Association recommends starting screening no later than age 35 if there are no other specific risk factors, and considering repeat testing at least every 3 years if the result is normal. Earlier testing may be needed in people who are overweight or obese, have a family history of diabetes, a history of gestational diabetes, polycystic ovary syndrome or high blood pressure.

 

When should bone density be measured?

Bone density measurement is generally recommended for screening in women aged 65 and over. Postmenopausal women younger than 65 may be assessed earlier if they have factors that increase the risk of osteoporosis and fractures.

 

Important reminder

Screening tests are intended to assess people who have no symptoms. If you have a new or ongoing symptom, it may not be appropriate to wait until you reach the “screening age” or your next routine check-up. Test selection should be planned by a doctor, taking your family history and health status into account. Click to view our check-up packages.

Popular Articles